National Health Investors Receivables

National Health Investors's receivables stands at $300M as of March 2026. That compares with $350M in the prior-year period — down 13.9% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

National Health Investors reported $300M in receivables versus $350M a year earlier — a 13.9% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $350M in the prior-year period — down 13.9% year over year. Sustained growth in receivables can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how National Health Investors's receivables evolved across reporting periods, while the comparison chart places NHI next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Finance, receivables is commonly used to spot outliers. National Health Investors's reading of $300M is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.